27623107Kanteti R, Riehm JJ, Dhanasingh I, Lennon FE, Mirzapoiazova T, Mambetsariev B, Kindler HL, Salgia RScientific reportsAntineoplastic Agents; Lung Neoplasms; Mesothelioma; Phosphoinositide-3 Kinase Inhibitors; Pleural Neoplasms; Proto-Oncogene Proteins c-metAminopyridines; Animals; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Crizotinib; Drug Synergism; Female; Humans; Mesothelioma, Malignant; Mice; Mice, Nude; Microtubules; Morpholines; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Pyrimidines; Signal Transduction; Xenograft Model Antitumor AssaysPI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma. Sci Rep. 2016 09 13; 6:32992.Sci Rep2016-09-13T00:00:002016PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000970Chemicals & Drugs40723510.435461Antineoplastic AgentsD000631Chemicals & Drugs27320.968218AminopyridinesD000818Living Beings1457265180.249624AnimalsD002465Physiology2507560.750985Cell MovementD004357Physiology1533030.932427Drug SynergismD008654Disorders573090.774622MesotheliomaD008819Living Beings2217900.84759Mice, NudeD008175Disorders32822600.404525Lung NeoplasmsD009025Chemicals & Drugs39650.961579MorpholinesD005260Physiology1992444050.191167FemaleD010997Disorders361880.842535Pleural NeoplasmsD011725Chemicals & Drugs1533090.839039PyridinesD006801Living Beings2262862810.130052HumansMedicine-Hematology and OncologyD008870Anatomy621170.940451MicrotubulesD017209Physiology41016780.608637ApoptosisD049109Physiology43515710.639735Cell ProliferationD051379Living Beings980113130.368397MiceD011720Chemicals & Drugs841530.896041PyrazolesD011743Chemicals & Drugs1373700.795259PyrimidinesD019859Chemicals & Drugs491990.86Proto-Oncogene Proteins c-metD023041Procedures1684580.868544Xenograft Model Antitumor AssaysD059447Physiology49630.957887Cell Cycle CheckpointsD045744Anatomy46824210.643233Cell Line, TumorD015398Physiology69932330.460036Signal TransductionD019086Chemicals & Drugs52760.95557Bridged Bicyclo Compounds, HeterocyclicD047428Chemicals & Drugs2065890.714193Protein Kinase InhibitorsMedicineUniversity of ChicagoRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, ProfessorHedyKindler32lgBaUZHP75hHlsaUXv9Gq0+s+oHedy Kindler41.78927490000000-87.601250000000002499Kindler, HedyProfessortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1ProfessorProfessorAuthorship 93832Authorship 938828Authorship 9383170.5930680.1482673authors10.2526has subject area